The miR-26a-5p/CHAC1/NF-kB axis highlights a potential therapeutic target, suggesting that enhancing miR-26a-5p levels could be beneficial in treating conditions characterized by excessive inflammation, such as DKD (Li S. et al., 2020). The gene discussed is CHAC1; the disease is diabetic kidney disease.